{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T15:03:19Z","timestamp":1726412599785},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00292-023-01188-3","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T17:02:43Z","timestamp":1679072563000},"page":"184-192","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Klassifikation der Hodgkin-Lymphome und verwandter Entit\u00e4ten","Classification of Hodgkin lymphoma and related entities"],"prefix":"10.1007","volume":"44","author":[{"given":"Sylvia","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"1188_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio\u00a0R, Amador\u00a0C, Anagnostopoulos\u00a0I et\u00a0al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"1188_CR2","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","volume":"113","author":"N Asano","year":"2009","unstructured":"Asano\u00a0N, Yamamoto\u00a0K, Tamaru\u00a0J et al (2009) Age-related Epstein-Barr virus (EBV)-associated B\u2011cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 113:2629\u20132636","journal-title":"Blood"},{"issue":"3","key":"1188_CR3","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/cancers14030742","volume":"14","author":"J Bosch-Schips","year":"2022","unstructured":"Bosch-Schips\u00a0J, Granai\u00a0M, Quintanilla-Martinez\u00a0L et al (2022) The grey zones of classic hodgkin lymphoma. Cancers 14(3):742","journal-title":"Cancers"},{"key":"1188_CR4","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo\u00a0E, Jaffe\u00a0ES, Cook\u00a0JR et\u00a0al (2022) The international consensus classification of mature lymphoid neoplasms: a\u00a0report from the clinical advisory committee. Blood 140:1229\u20131253","journal-title":"Blood"},{"key":"1188_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/PDM.0b013e318150d695","volume":"17","author":"DJ Chute","year":"2008","unstructured":"Chute\u00a0DJ, Cousar\u00a0JB, Mahadevan\u00a0MS et al (2008) Detection of immunoglobulin heavy chain gene rearrangements in classic hodgkin lymphoma using commercially available BIOMED\u20112 primers. Diagn Mol Pathol 17:65\u201372","journal-title":"Diagn Mol Pathol"},{"key":"1188_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/pathogens7010028","volume":"7","author":"SD Dojcinov","year":"2018","unstructured":"Dojcinov\u00a0SD, Fend\u00a0F, Quintanilla-Martinez\u00a0L (2018) EBV-positive lymphoproliferations of B\u2011 T\u2011 and NK-cell derivation in non-immunocompromised hosts. Pathogens 7:28","journal-title":"Pathogens"},{"key":"1188_CR7","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","volume":"117","author":"SD Dojcinov","year":"2011","unstructured":"Dojcinov\u00a0SD, Venkataraman\u00a0G, Pittaluga\u00a0S et al (2011) Age-related EBV-associated lymphoproliferative disorders in the Western population: a\u00a0spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 117:4726\u20134735","journal-title":"Blood"},{"key":"1188_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","volume":"34","author":"SD Dojcinov","year":"2010","unstructured":"Dojcinov\u00a0SD, Venkataraman\u00a0G, Raffeld\u00a0M et\u00a0al (2010) EBV positive mucocutaneous ulcer\u2014a study of 26\u00a0cases associated with various sources of immunosuppression. Am J Surg Pathol 34:405\u2013417","journal-title":"Am J Surg Pathol"},{"key":"1188_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3324\/haematol.2010.033167","volume":"96","author":"FC Eberle","year":"2011","unstructured":"Eberle\u00a0FC, Rodriguez-Canales\u00a0J, Wei\u00a0L et al (2011) Methylation profiling of mediastinal gray zone lymphoma reveals a\u00a0distinctive signature with elements shared by classical Hodgkin\u2019s lymphoma and primary mediastinal large B\u2011cell lymphoma. Haematologica 96:558\u2013566","journal-title":"Haematologica"},{"key":"1188_CR10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","volume":"27","author":"Z Fan","year":"2003","unstructured":"Fan\u00a0Z, Natkunam\u00a0Y, Bair\u00a0E et\u00a0al (2003) Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 27:1346\u20131356","journal-title":"Am J Surg Pathol"},{"key":"1188_CR11","doi-asserted-by":"publisher","first-page":"e78812","DOI":"10.1371\/journal.pone.0078812","volume":"8","author":"S Hartmann","year":"2013","unstructured":"Hartmann\u00a0S, Doring\u00a0C, Jakobus\u00a0C et\u00a0al (2013) Nodular lymphocyte predominant hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma\u2014endpoints of a\u00a0spectrum of one disease? Plos One 8:e78812","journal-title":"Plos One"},{"key":"1188_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/bjh.13310","volume":"169","author":"S Hartmann","year":"2015","unstructured":"Hartmann\u00a0S, Doring\u00a0C, Vucic\u00a0E et\u00a0al (2015) Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma. Br J Haematol 169:415\u2013422","journal-title":"Br J Haematol"},{"key":"1188_CR13","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","volume":"122","author":"S Hartmann","year":"2013","unstructured":"Hartmann\u00a0S, Eichenauer\u00a0DA, Plutschow\u00a0A et al (2013) The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a\u00a0report from the German Hodgkin Study Group (GHSG). Blood 122:4246\u20134252","journal-title":"Blood"},{"key":"1188_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41379-018-0108-5","volume":"32","author":"S Hartmann","year":"2019","unstructured":"Hartmann\u00a0S, Goncharova\u00a0O, Portyanko\u00a0A et\u00a0al (2019) CD30 expression in neoplastic T cells of follicular T cell lymphoma is a\u00a0helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma. Mod Pathol 32:37\u201347","journal-title":"Mod Pathol"},{"key":"1188_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25607","author":"S Hartmann","year":"2019","unstructured":"Hartmann\u00a0S, Plutschow\u00a0A, Mottok\u00a0A et\u00a0al (2019) The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.25607","journal-title":"Am J Hematol"},{"key":"1188_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/leu.2015.328","volume":"30","author":"S Hartmann","year":"2016","unstructured":"Hartmann\u00a0S, Schuhmacher\u00a0B, Rausch\u00a0T et\u00a0al (2016) Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia 30:844\u2013853","journal-title":"Leukemia"},{"key":"1188_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/bjh.18376","volume":"199","author":"S Hartmann","year":"2022","unstructured":"Hartmann\u00a0S, Soltani\u00a0AS, Bankov\u00a0K et al (2022) Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma. Br J Haematol 199:382\u2013391","journal-title":"Br J Haematol"},{"key":"1188_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/095952873201700106","volume":"17","author":"Hodgkin","year":"1832","unstructured":"Hodgkin (1832) On some morbid appearances of the absorbent glands and spleen. Med Chir Trans 17:68\u2013114","journal-title":"Med Chir Trans"},{"key":"1188_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1056\/NEJM194601102340201","volume":"234","author":"H Jackson Jr.","year":"1946","unstructured":"Jackson\u00a0H Jr., Parker\u00a0F Jr. (1946) Hodgkin\u2019s disease; clinical diagnosis. N\u00a0Engl J Med 234:37\u201341","journal-title":"N Engl J Med"},{"key":"1188_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1056\/NEJM194601242340401","volume":"234","author":"H Jackson Jr.","year":"1946","unstructured":"Jackson\u00a0H Jr., Parker\u00a0F Jr. (1946) Hodgkin\u2019s disease; treatment and prognosis. N\u00a0Engl J Med 234:103\u2013110","journal-title":"N Engl J Med"},{"key":"1188_CR21","volume-title":"WHO classification of tumors: pathology and genetics of tumors of Haematopoietic and lymphoid tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe\u00a0ES, Harris\u00a0NL, Stein\u00a0H et\u00a0al (2001) WHO classification of tumors: pathology and genetics of tumors of Haematopoietic and lymphoid tissues. IARC Press, Lyon"},{"key":"1188_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ijc.10845","volume":"103","author":"S Joos","year":"2003","unstructured":"Joos\u00a0S, Granzow\u00a0M, Holtgreve-Grez\u00a0H et al (2003) Hodgkin\u2019s lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer 103:489\u2013495","journal-title":"Int J Cancer"},{"key":"1188_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1182\/blood.V99.4.1381","volume":"99","author":"S Joos","year":"2002","unstructured":"Joos\u00a0S, Menz\u00a0CK, Wrobel\u00a0G et\u00a0al (2002) Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 99:1381\u20131387","journal-title":"Blood"},{"key":"1188_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nri1201","volume":"3","author":"R K\u00fcppers","year":"2003","unstructured":"K\u00fcppers\u00a0R (2003) B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 3:801\u2013812","journal-title":"Nat Rev Immunol"},{"key":"1188_CR25","doi-asserted-by":"publisher","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","volume":"91","author":"R K\u00fcppers","year":"1994","unstructured":"K\u00fcppers\u00a0R, Rajewsky\u00a0K, Zhao\u00a0M et al (1994) Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 91:10962\u201310966","journal-title":"Proc Natl Acad Sci USA"},{"key":"1188_CR26","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/ijc.24502","volume":"125","author":"A Lake","year":"2009","unstructured":"Lake\u00a0A, Shield\u00a0LA, Cordano\u00a0P et al (2009) Mutations of NFKBIA, encoding IkappaB alpha, are a\u00a0recurrent finding in classical Hodgkin lymphoma but are not a\u00a0unifying feature of non-EBV-associated cases. Int J Cancer 125:1334\u20131342","journal-title":"Int J Cancer"},{"key":"1188_CR27","first-page":"1063","volume":"26","author":"RJ Lukes","year":"1966","unstructured":"Lukes\u00a0RJ, Butler\u00a0JJ (1966) The pathology and nomenclature of Hodgkin\u2019s disease. Cancer Res 26:1063\u20131083","journal-title":"Cancer Res"},{"key":"1188_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","volume":"126","author":"A Nicolae","year":"2015","unstructured":"Nicolae\u00a0A, Pittaluga\u00a0S, Abdullah\u00a0S et al (2015) EBV-positive large B\u2011cell lymphomas in young patients: a\u00a0nodal lymphoma with evidence for a\u00a0tolerogenic immune environment. Blood 126:863\u2013872","journal-title":"Blood"},{"key":"1188_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00292-022-01081-5","volume":"43","author":"M Overkamp","year":"2022","unstructured":"Overkamp\u00a0M, Quintanilla-Martinez\u00a0L, Fend\u00a0F (2022) EBV-associated lymphoproliferative disorders. Pathologie 43:282\u2013291","journal-title":"Pathologie"},{"key":"1188_CR30","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","volume":"13","author":"T Oyama","year":"2007","unstructured":"Oyama\u00a0T, Yamamoto\u00a0K, Asano\u00a0N et al (2007) Age-related EBV-associated B\u2011cell lymphoproliferative disorders constitute a\u00a0distinct clinicopathologic group: a\u00a0study of 96\u00a0patients. Clin Cancer Res 13:5124\u20135132","journal-title":"Clin Cancer Res"},{"key":"1188_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1158\/2643-3230.BCD-20-0009","volume":"1","author":"S Pittaluga","year":"2020","unstructured":"Pittaluga\u00a0S, Nicolae\u00a0A, Wright\u00a0GW et al (2020) Gene expression profiling of mediastinal gray zone lymphoma and its relationship to primary mediastinal B\u2011cell lymphoma and classical Hodgkin lymphoma. Blood Cancer Discov 1:155\u2013161","journal-title":"Blood Cancer Discov"},{"key":"1188_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2559.1979.tb03011.x","volume":"3","author":"S Poppema","year":"1979","unstructured":"Poppema\u00a0S, Kaiserling\u00a0E, Lennert\u00a0K (1979) Hodgkin\u2019s disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres\u2014a cytohistological study. Histopathology 3:295\u2013308","journal-title":"Histopathology"},{"key":"1188_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF02889938","volume":"31","author":"S Poppema","year":"1979","unstructured":"Poppema\u00a0S, Kaiserling\u00a0E, Lennert\u00a0K (1979) Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol 31:211\u2013225","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"1188_CR34","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1097\/00000478-199910000-00008","volume":"23","author":"L Quintanilla-Martinez","year":"1999","unstructured":"Quintanilla-Martinez\u00a0L, Fend\u00a0F, Moguel\u00a0LR et al (1999) Peripheral T\u2011cell lymphoma with Reed-Sternberg-like cells of B\u2011cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol 23:1233\u20131240","journal-title":"Am J Surg Pathol"},{"key":"1188_CR35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","volume":"125","author":"J Reichel","year":"2015","unstructured":"Reichel\u00a0J, Chadburn\u00a0A, Rubinstein\u00a0PG et al (2015) Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood 125:1061\u20131072","journal-title":"Blood"},{"issue":"Suppl 5","key":"1188_CR36","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1093\/annonc\/9.suppl_5.S31","volume":"9","author":"T Rudiger","year":"1998","unstructured":"Rudiger\u00a0T, Jaffe\u00a0ES, Delsol\u00a0G et\u00a0al (1998) Workshop report on Hodgkin\u2019s disease and related diseases (\u2019grey zone\u2018 lymphoma). Ann Oncol 9(Suppl 5):S31\u2013S38","journal-title":"Ann Oncol"},{"key":"1188_CR37","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1182\/blood.2020007507","volume":"137","author":"C Sarkozy","year":"2021","unstructured":"Sarkozy\u00a0C, Hung\u00a0SS, Chavez\u00a0EA et\u00a0al (2021) Mutational landscape of gray zone lymphoma. Blood 137:1765\u20131776","journal-title":"Blood"},{"key":"1188_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.20090528","volume":"206","author":"R Schmitz","year":"2009","unstructured":"Schmitz\u00a0R, Hansmann\u00a0ML, Bohle\u00a0V et\u00a0al (2009) TNFAIP3 (A20) is a\u00a0tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J\u00a0Exp Med 206:981\u2013989","journal-title":"J Exp Med"},{"key":"1188_CR39","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3324\/haematol.2018.203224","volume":"104","author":"B Schuhmacher","year":"2019","unstructured":"Schuhmacher\u00a0B, Bein\u00a0J, Rausch\u00a0T et al (2019) JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T\u2011cell\/histiocyte-rich large B\u2011cell lymphoma. Haematologica 104:330\u2013337","journal-title":"Haematologica"},{"issue":"2","key":"1188_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/bjh.13540","volume":"171","author":"AG Shankar","year":"2015","unstructured":"Shankar\u00a0AG, Kirkwood\u00a0AA, Hall\u00a0GW et al (2015) Childhood and adolescent nodular lymphocyte predominant Hodgkin lymphoma\u2014A review of clinical outcome based on the histological variants. Br J Haematol 171(2):254\u2013262. https:\/\/doi.org\/10.1111\/bjh.13540","journal-title":"Br J Haematol"},{"key":"1188_CR41","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/10428190902930488","volume":"50","author":"GW Slack","year":"2009","unstructured":"Slack\u00a0GW, Ferry\u00a0JA, Hasserjian\u00a0RP et\u00a0al (2009) Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis. Leuk Lymphoma 50:937\u2013943","journal-title":"Leuk Lymphoma"},{"key":"1188_CR42","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","volume":"131","author":"E Tiacci","year":"2018","unstructured":"Tiacci\u00a0E, Ladewig\u00a0E, Schiavoni\u00a0G et al (2018) Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. Blood 131:2454\u20132465","journal-title":"Blood"},{"key":"1188_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00428-022-03427-z","volume":"482","author":"TA Tousseyn","year":"2023","unstructured":"Tousseyn\u00a0TA, King\u00a0RL, Fend\u00a0F et al (2023) Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities. Virchows Arch 482:207\u2013226","journal-title":"Virchows Arch"},{"key":"1188_CR44","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","volume":"29","author":"A Traverse-Glehen","year":"2005","unstructured":"Traverse-Glehen\u00a0A, Pittaluga\u00a0S, Gaulard\u00a0P et al (2005) Mediastinal gray zone lymphoma: the missing link between classic Hodgkin\u2019s lymphoma and mediastinal large B\u2011cell lymphoma. Am J Surg Pathol 29:1411\u20131421","journal-title":"Am J Surg Pathol"},{"key":"1188_CR45","unstructured":"https:\/\/tumourclassification.iarc.who.int"},{"issue":"3","key":"1188_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/pathogens7030059","volume":"7","author":"K Vrzalikova","year":"2018","unstructured":"Vrzalikova\u00a0K, Sunmonu\u00a0T, Reynolds\u00a0G et al (2018) Contribution of Epstein(-)Barr virus latent proteins to the pathogenesis of classical Hodgkin lymphoma. Pathogens 7(3):59. https:\/\/doi.org\/10.3390\/pathogens7030059","journal-title":"Pathogens"},{"key":"1188_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/ajcp\/aqab113","volume":"157","author":"D Xia","year":"2022","unstructured":"Xia\u00a0D, Sayed\u00a0S, Moloo\u00a0Z et al (2022) Geographic variability of nodular lymphocyte-predominant Hodgkin lymphoma. Am J Clin Pathol 157:231\u2013243","journal-title":"Am J Clin Pathol"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01188-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-023-01188-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01188-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T18:03:02Z","timestamp":1683223382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-023-01188-3"}},"subtitle":["Neuigkeiten und offene Fragen","News and open questions"],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1188"],"URL":"https:\/\/doi.org\/10.1007\/s00292-023-01188-3","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"type":"print","value":"2731-7188"},{"type":"electronic","value":"2731-7196"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"12 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Hartmann und F.\u00a0Fend geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}